Patient, Provider, & Institutional Effects on Latinos
The overarching aim of this study is to identify the most promising targets for interventions designed to enable Latinos to receive: a) high quality EOL care, and b) care consistent with their values and preferences ([Double Quote]treatment goal attainment[Double Quote]).
We propose to recruit 75 advanced gastrointestinal, thoracic, and ovarian cancer Latino patients with a life-expectancy of less than 6 months to estimate the relative magnitude of patient-, provider-, and institution-level effects on patient EOL outcomes. Recruitment of patients for two interviews is expected to occur over a 2-year period, leaving the final year for follow-up chart review postmortem assessments occurring on average 6 months after the initial patient assessment.
1. Latino cancer patients with advanced cancer who have failed first-line chemotherapy and who have either
a. thoracic (pulmonary, mediastinal, pericardial, and pleural lesions, and cancers affecting the chest wall and sternum),
b. GI (esophageal, pancreatic, liver, gastric and stomach, not colon) and
c. platinum refractory/resistant ovarian cancer and who are still getting chemotherapy